Accelerating precision probiotic interventions by identifying subgroups of responders through unique biological patterns, aiming to enhance clinical outcomes.
Accelerate precision probiotic therapies by identifying person-specific features affecting probiotic responses to enhance clinical outcomes.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.
NIH funds two-phase clinical trials studying how mind and body interventions affect emotional well-being mechanisms and whole person health, with full-scale trials contingent on feasibility milestones.
NIH supports milestone-driven Down syndrome clinical trial development with up to two years of planning and a possible three-year clinical trial phase, for a maximum of five years.
Supporting feasibility trials of mind and body interventions for high-priority health conditions to inform future clinical trials for enhanced public health impact.